iShares US Pharmaceuticals ETF
IHE
IHE
127 hedge funds and large institutions have $127M invested in iShares US Pharmaceuticals ETF in 2023 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 29 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
17% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 18
Holders
127
Holding in Top 10
–
Calls
$421K
Puts
–
Top Buyers
| 1 | +$5.64M | |
| 2 | +$4.27M | |
| 3 | +$3.8M | |
| 4 |
Jane Street
New York
|
+$2.35M |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$1.46M |
Top Sellers
| 1 | -$8.21M | |
| 2 | -$5.35M | |
| 3 | -$3.73M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.59M |
| 5 |
Morgan Stanley
New York
|
-$1.7M |